Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Milan - Delayed Quote EUR

BIOMARIN PHARMACEUTICAL (1BMRN.MI)

Compare
67.02
+1.38
+(2.10%)
At close: March 7 at 10:00:00 AM GMT+1
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
572,841
572,841
159,259
175,902
304,536
Investing Cash Flow
136,491
136,491
-111,244
-20,029
-366,313
Financing Cash Flow
-526,447
-526,447
-18,727
-18,650
-48
End Cash Position
942,842
942,842
755,127
724,531
587,276
Income Tax Paid Supplemental Data
57,269
57,269
73,312
54,372
18,153
Interest Paid Supplemental Data
10,361
10,361
10,303
10,281
10,395
Capital Expenditure
-97,418
-97,418
-107,611
-131,540
-119,225
Repayment of Debt
-494,987
-494,987
--
--
-3,039
Free Cash Flow
475,423
475,423
51,648
44,362
185,311
12/31/2021 - 1/3/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1MRNA.MI Moderna, Inc.
33.97
+6.21%
 
IPSC Century Therapeutics, Inc.
0.6554
+0.06%
 
BCAB BioAtla, Inc.
0.3449
+4.83%
 
PRME Prime Medicine, Inc.
2.4000
+4.35%
 
CTMX CytomX Therapeutics, Inc.
0.6649
+7.71%
 
RXRX Recursion Pharmaceuticals, Inc.
6.59
+5.61%
 
MRNA Moderna, Inc.
35.61
+3.82%